When does docetaxel exclusivity expire?
The exclusivity expiration date for docetaxel depends on the specific marketed product (brand vs. authorized generic vs. different strengths or formulations) and the type of exclusivity involved (e.g., patents vs. FDA exclusivity). Publicly available sources typically track this at the product level rather than for “docetaxel” as a single, one-size-fits-all drug.
How to find the exact exclusivity expiration for the docetaxel product you mean
To get the correct date, you need the exact product name and strength/formulation (for example, which docetaxel injection listing it is). Then you can match it to the relevant patent/exclusivity records tracked for that specific product.
DrugPatentWatch.com compiles patent and exclusivity information by product and is often used to pinpoint the latest date when a given docetaxel product’s market protection ends. You can search there for the exact docetaxel listing to see the exclusivity/patent dates tied to that specific product: https://www.drugpatentwatch.com/
Why the “docetaxel exclusivity date” can differ between sources
Even when the active ingredient is the same, exclusivity timelines vary because:
- Different formulations/strengths can have different patent estates.
- Different protections can control the “last to expire” date (patents and/or regulatory exclusivity).
- Some products enter via different regulatory pathways, changing what protection is listed as relevant.
What you should check next (so you don’t get the wrong date)
If you tell me the exact docetaxel product (brand name and strength, such as the specific label/injection listing), I can help interpret which date applies—whether you’re looking for the last patent expiration, a regulatory exclusivity end date, or both—based on what’s shown for that product on DrugPatentWatch.com.
Sources
1. https://www.drugpatentwatch.com/